Karyopharm Therapeutics | KPTI - Ebitda





Ebitda Zmiana Data
AbbVie USD 3.69B 1.68B 2026-03
Abbott USD 2.43B 844M 2026-03
Amgen USD 3.86B 1.28B 2026-03
AstraZeneca USD 5.16B 510M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Incyte USD 778.57M 410.6M 2026-06
J&J USD 8.27B 1.08B 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -30.2M 52.15M 2026-03
Merck USD -1.54B 7.84B 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novartis USD 5.41B 431M 2026-03
Pfizer USD 6.01B 18M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Takeda JPY 364.46B 214.21B 2026-06
Tectonic Therapeutic USD -21.18M 365K 2025-12
TG Therapeutics USD 26.9M 1.21M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Xencor USD -34.63M 86.74M 2026-06